The perinatal changes in the pattern of expression of the thyroid hormone receptor (TR) isoforms TRa 1 TRa 2 , TRb 1 , and TRb 2 were investigated using in situ hybridization and immunohistochemistry, and RT-PCR and western blotting as visualization and quantification techniques respectively. In liver, lung, and kidney, TRa mRNA was expressed in the stromal and TRb mRNA in the parenchymal component of the tissues. When compared with liver, TRa mRNA concentrations were tenfold higher in lung, kidney, and intestine, and 100-fold higher in brain, with TRa 2 mRNA concentrations exceeding those of TRa 1 5-to 10-fold. Tissue TRb 1 mRNA concentrations were similar in liver, lung, and brain, and 3-to 5-fold higher in kidney and intestine. None of the TRb 2 mRNA could be detected outside the pituitary. Tissue TRa 2 and TRb 1 protein levels reached adult levels at 5 days before birth, whereas TRa 1 protein peaked after birth. Because of the distinct time-course of thyroid hormonebinding receptors TRa 1 and TRb 1 , we speculate that an initiating, TRb 1 -mediated signaling from the parenchyma is followed by a TRa 1 -mediated response in the stroma. When compared with organs with a complementary parenchymal-stromal expression pattern, organs with extensive cellular co-expression of TRa and TRb (brain and intestinal epithelium) were characterized by a very low TRa protein: mRNA ratio, implying a low translational efficiency of TR mRNA or a high turnover of TR protein. The data indicate that the TR-dependent regulatory cascades are controlled differently in organs with a complementary tissue expression pattern and in those with cellular co-expression of the TRa and TRb genes.
Introduction
Since it was discovered that metamorphosis can be induced in amphibians by feeding them thyroid gland extract (Gudernatsch 1912) , it has become generally accepted that thyroid hormones play a crucial role in controlling growth, development, differentiation, and metabolism of virtually all tissues of vertebrates. The beneficial effects of thyroid hormones on perinatal organ development and maturation are most readily recognizable in brain (Oppenheimer & Schwartz 1997 , Morreale de Escobar et al. 2004 . However, since thyroid hormones can pass the placenta and accumulate in embryonic cells to functionally relevant concentrations well before the embryonic thyroid starts to function on its own (Morreale de Escobar et al. 1990) , thyroid hormone-dependent instructive effects in earlier phases of organ development are likely (Glinoer 2001 , van Tuyl et al. 2004 ).
The effects of thyroid hormones on gene expression are mediated via the thyroid hormone receptor (TR) genes a (NR1A1) and b (NR1A2), which are both the members of the steroid/TR superfamily of liganddependent transcription factors (Zhang & Lazar 2000 , Yen 2001 , Yen et al. 2006 ). The TRa and TRb genes generate, via alternative splicing, four thyroid hormone-binding receptors, namely TRa 1 and TRb 1-3 (Williams 2000 , Chassande 2003 ). In addition, several proteins, including TRa 2 , which do not bind thyroid hormone-response elements and/or thyroid hormones, are formed. Presumably, these proteins modulate thyroid hormone-mediated gene expression (Cheng 2000 , Williams 2000 , Plateroti et al. 2001 , Yen 2001 .
In rat, northern blot analysis showed that TRa mRNA concentration increased in brain, liver, and brown adipose tissue from 18 days of development onwards to reach its highest level perinatally (Strait et al. 1990 , Tuca et al. 1993 . TRb mRNA also increased perinatally in brain, but was reported to reach its peak only in the second postnatal week (Strait et al. 1990 ). In contrast, TRb mRNA decreased perinatally in liver and brown adipose tissue (Strait et al. 1990 , Tuca et al. 1993 . In the developing nervous system of the rat, the highest cellular concentration of TRa mRNAs was found in the areas of neuronal differentiation such as the fetal neocortical plate, whereas TRb mRNAs were largely restricted to the zones with neuroblast proliferation, such as the germinal trigone and the cortical ventricular layer (Bradley et al. 1992) . Although these findings suggested complementary and, perhaps, mutually exclusive roles of the TRa and TRb genes in organogenesis, they did not result in a specific hypothesis for the mechanism of action of thyroid hormones in development. Furthermore, these studies did not address TR expression at the protein level. We, therefore, studied the spatial and the temporal distribution of the mRNAs and proteins encoding TRa and TRb by in situ hybridization and immunohistochemistry. Since our in situ probes did not differentiate between the respective splice variants, quantitative PCR techniques were used to determine the tissue levels of TRa 1 , TRa 2 , TRb 1 , and TRb 2 mRNA. Since tissue TR mRNA level and nuclear thyroid hormone-binding capacity (i.e., functional TR protein) do not always correlate (Strait et al. 1990 , Tuca et al. 1993 , we also investigated tissue TR protein level by western blot analysis and immunohistochemistry, using our recently described antisera (Zandieh Doulabi et al. 2002 , 2003 . We report a highly specific, but heterogeneous spatial and temporal expression pattern of the TRa and TRb mRNAs, and report evidence for extensive posttranscriptional regulation in the perinatal period.
Materials and methods

Animals
Female Wistar rats in heat were selected and mated in the morning, the next day being designated embryonic day 1 (E1). Fetuses were harvested by caesarian section at E13, E14, E15, E16, E17, E18, E19, and E20; or were born naturally and killed 1 (P1) or 4 days (P4) later, or as adults. All experiments were performed under protocols approved by the University of Amsterdam Committee on Animal Research.
Tissue isolation and preparation
All tissues were fixed in phosphate-buffered 4% formaldehyde for in situ hybridization and in the ratio of methanol:acetone:water (2:2:1 (v/v)) for immunohistochemistry as described (van Tuyl et al. 2004) .
In situ hybridization
In situ hybridization was carried out exactly as described (Moorman et al. 2000) . In situ hybridization carried out according to this protocol produces semiquantitative data, that is, differences in absorbance between different tissues or cells within one section reflect differences in mRNA concentration between these tissues or cells (Jonker et al. 1997 ). This protocol is included in the method paper referenced to Moorman et al. (2000) . The EcoRI-HindIII cDNA fragments of the clones rc-erbA-a (nt K29 to C1821) and rc-erbA-b (nt K37 to C2165) were used as probes to detect TRa and TRb mRNA respectively (Bradley et al. 1992) . These fragments do not discriminate between TR isoforms. [a-
35
S]UTP-labeled antisense and sense probes were generated with Sp6 and T7 RNA polymerase respectively. We opted to use almost the entire TR mRNA sequence to make the in situ assay as sensitive as possible, because the hybridization signal is dependent on the length of the probe (before fragmentation). We then used PCR to quantify subtypes.
Quantitative PCR
At E15, E18, P1, and in the adult, TR mRNA levels were quantified in brain, pituitary gland, lung, liver, kidney, and intestines. For each stage, minimally three rats were assayed. TR mRNAs were quantified by establishing the efficiency of both the reverse-transcription and polymerase chain reaction steps of the assay. Large-scale mRNA synthesis from the respective TR cDNA fragments was performed with the MEGAshortscript T7 Kit (Ambion, Nieuwerkerk a/d IJssel, The Netherlands) and quantified by including a known amount of [a- 35 S]CTP. Reverse-transcriptase efficiency was estimated by comparing mRNA input (different amounts of the RNA transcripts) and DNA output, and amounted to 80-100%. TRa cDNA amplification was estimated by competitive RT-PCR as described (Moller & Jansson 1997) , whereas TRb cDNA amplification was measured by real-time PCR (Lightcycler, Roche).
TRa
The sense primer was chosen in the common part of the TRa 1 and TRa 2 sequences, whereas the antisense primers were in the specific parts. For TRa 1 , a 343 bp fragment was formed (nt 1219-1562 of the mRNA) and for TRa 2 a 242 bp fragment (nt 1411-1653). After reverse transcription (RT) and PCR amplification, the concentration of TRa 1 and TRa 2 cDNA in the sample was estimated by titration of 8-5000!10 K4 amol (TRa 1 ) or 4-2500!10 K3 amol (TRa 2 ) of a 'competimer' fragment that differed from the parent fragments by missing an identical 82 bp 5 0 HincII fragment.
The amount of competimer added was determined by including a known amount of [a-35 S]dATP during large-scale PCR synthesis. TRa mRNA concentration in the sample was calculated from a double logarithmic plot of the TRa:competimer ratio and the competimer concentration (Moller & Jansson 1997) .
TRb
The antisense primer was chosen in the common part of TRb 1 and TRb 2 , whereas the sense primers were in the specific part. For TRb 1 , a 185 bp fragment was formed (nt 437-622 of the mRNA) and for TRb 2 , a 244 bp fragment (nt 343-587 of the mRNA). TRb cDNA concentration in the sample was deduced from a standard curve with 5-50 000!10 K4 amol TRb 1 or TRb 2 DNA fragment. The TRb 1 and TRb 2 fragments were made by large scale PCR synthesis and quantified by including a known amount of [a- 32 P]dATP. TRb 2 levels were also quantified with fluorescence resonance energy transfer of hybridization probes nt 264-290 (red640-labeled) and nt 292-316 (fluorescein-labeled) on amplified fragment nt 241-556. Dilutions of pituitary gland mRNA with a predetermined TRb 2 mRNA concentration were used to generate a standard curve.
Western blotting and immunohistochemistry
Extracts of brain, pituitary gland, thyroid, trachea, lung, heart, muscle, liver, intestines, kidneys, adrenals, testis, epididymal fat pad, bladder, and spleen from 3 E17, P4, and adult rats were analyzed in triplicate by western blotting, using antisera specifically identifying TRa 1 , TRa 2 , and TRb 1 . The specificity of the antibodies used was described previously (Zandieh Doulabi et al. 2002 , 2003 . The extracts were prepared in 0 . 25 M sucrose, 40 mM dithiothreitol, 2% SDS, 1 mM EDTA, 62 . 5 mM Tris-HCl (pH 7 . 6), and 10% glycerol, separated on 10% (w/v) polyacrylamide gels, and blotted onto an Immobilon-P (Millipore) membrane. After staining with amido black to verify similar protein loading, the membrane was incubated in 10 mM Tris-HCl (pH 8 . 0), 150 mM NaCl, 0 . 5% Tween20, and 5% nonfat dried milk powder (Natrinon, Nutricia) for 6 h, followed by an overnight incubation in a ratio of 1:1000 dilution of the respective antisera. Antibody binding was quantified using chemiluminescence (CDP-Star, Roche), in combination with the LUMI-imager F1 (Roche; Bakker 1998). In the absence of primary antisera, no staining was seen, whereas in their presence, bands at the anticipated M r of the corresponding receptors appeared. However, in liver and kidney extracts, extra bands at both higher and lower M r than found in other organs were observed for TRa 1 and TRb 1 . These patterns were also found in organs that were rapidly isolated and analyzed immediately.
Immunoperoxidase staining was performed on dewaxed tissue sections. Antibody binding on sections was visualized by the indirect unlabeled antibody peroxidase anti-peroxidase (PAP) method (Sternberger et al. 1970) . PAP immunocomplexes were purchased from Nordic (Tilburg, The Netherlands). If care is taken not to overdevelop 
the enzymic staining, local differences in immunohistochemical staining intensity represent differences in protein concentration between these cells or tissues (van Straaten et al. 2006) .
Results
Distribution of TRa and TRb
We describe the expression patterns TRa and TRb for each organ separately, going from mRNA to protein and from early fetal to postnatal. An overview of our findings is provided in Table 1 .
Central nervous system
The staining pattern of TRs in the central nervous system has been described (Bradley et al. 1992) . In agreement, TRa mRNA expression in the basal plate of the neural tube was already pronounced at E15 ( Fig. 1A ) and very strong in the cortical plate of the brain at E16 (Fig. 1C ). In contrast, TRb mRNA expression was undetectable (Fig. 1B ) or much weaker ( Fig. 1D ). Since the TRa 2 mRNA concentration exceeded that of TRa 1 more than 20-fold ( Fig. 2A) , it was responsible for the observed TRa mRNA expression pattern. The expression of TRa 2 and TRb 1 mRNA followed a similar temporal pattern and was highest at P1 ( Fig. 2A ). TRb 2 mRNA was not detectable. Both before and shortly after birth, the TRa 1 and TRa 2 protein concentration in the brain (Fig. 1G , H, J and K) was very low when compared with that in the other organs ( Fig. 3A-F ). In contrast, TRb 1 protein was already present in fetal brain (E17) and abundant at P4 (Figs 1I, L and 3). These data show that the developing brain was characterized by a very low protein: mRNA ratio for TRa 1 and, in particular TRa 2 , whereas this ratio was much higher for TRb 1 . A summary of these findings can be found in Table 1 .
Other intracranial organs
TRa and TRb expression colocalized at many sites in the central nervous tissue. In the inner ear, however, the strong signal of TRb mRNA in the sensory epithelium of the cochlea and the very weak signal in the cochlear nerve ( Fig. 1F ) contrasts with the opposite staining pattern TRa mRNA ( Fig. 1E ) and demonstrates the specificity of the in situ hybridization procedure. We have included this result as an example of the sometimes highly contrasting TR expression patterns in organs. Protein for all the three receptors was observed in the extracts of adult pituitary glands ( . In contrast, the TRb signal is intense in the cochlear sensory epithelium (F), whereas TRa expression dominates in the cochlear nerves (E). At E18 and P4, protein expression of TRa 1 and TRa 2 is very low (G, H, J and K). In contrast, TRb 1 protein is highly expressed in various structures of the brain (I and L). B, basal nuclei; C, cochlea; Ce, cerebellum; Co, cortex; CP, choroid plexus; N, nose. Bar, 100 mm.
glands, with the highest concentration in the posterior lobe ( Fig. 4C and F) . Both TRa isoforms only became detectable after birth in the anterior and middle lobes (Fig. 4A , B, D and E).
Lung
The pulmonary epithelium is initially surrounded by a conspicuous mass of mesenchyme. Expression of TRa mRNA in this mesenchyme was first observed at E13 and became pronounced at E15 (Fig. 5A ). TRb mRNA expression in the epithelium became more intense during the subsequent 'canalicular' phase of the lung development (E16-E18; Fig. 5B and D) , when TRa mRNA expression remained distinctly present in the mesenchyme (Fig. 5C ). Owing to the attenuation of the walls of the airways during the 'alveolar' phase of lung development (OE19), the complementary expression pattern of TRa and TRb became more and more difficult to discern (Fig. 5E and F) . TRb mRNA remained present in the wall of the pulmonary arteries (arrows Fig. 5D and F) and TRa mRNA in the myocardium of the pulmonary veins (arrows Fig. 5C ). TRa 2 mRNA levels were approx. tenfold higher than TRa 1 mRNA levels and peaked at E18 and P1 (Fig. 2B) , indicating that the TRa in situ hybridization signal actually represented TRa 2 mRNA. The TRb signal in the in situ hybridizations represented TRb 1 , because no TRb 2 mRNA could be detected. TRb 1 mRNA levels peaked at E18 (Fig. 2B) . Western blot analysis revealed the presence of TRa 1 protein at E17 and a marked increase in the concentration by P4 (Fig. 3A and B) . At the same time points, the intensity of the TRa 2 -protein band was relatively weak and even appeared to decrease with development ( Fig. 3D and E) . TRb 1 protein levels were similar at E17 and P4 ( Fig. 3G and H) . Despite the positive western blots, we were not able to demonstrate Expression of TRa and -b in developing tissues . R KEIJZER, P-J E BLOMMAART and others 527
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Liver
Expression of TRa mRNA in the liver was first observed at E15 (Fig. 6A ) and could be located in the stromal component, including the wall of the veins, from E17 onwards ( Fig. 6C and E) . Expression of TRb mRNA was also observed at E15, declined during the next 2 days to undetectable levels, but reappeared in the parenchymal tissue at E19 (Fig. 6B, D and F) . At E20, the complementary expression of TRa in the stromal and of TRb in the parenchymal tissue had become very striking ( Fig. 6E and F) . The concentration of TRa 1 and, in particular, TRa 2 mRNA, was very low when compared with other tissues during all ages investigated (Fig. 2C) . As a result, the TRa 1 : TRa 2 ratio was the highest observed in any of the tissues investigated and was more than five times higher than that in the brain. TRb 1 mRNA levels peaked at E18 (Fig. 2C) , whereas TRb 2 mRNA levels were undetectable. In liver extracts, the TRa 1 antibody detected not only a band at the expected size (47 kDa) but also bands at higher and lower M r s. TRa 1 levels increased between E17 and P4, when concentrations reached adult values ( Fig. 3A and B) , whereas the TRa 2 protein did not change ( Fig. 3D and E) . Similarly, the 57 kDa TRb 1 band did not change in development, but bands of 30 and 110 kDa became increasingly prominent ( Fig. 3G  and H Fig. 6H and K) . In fetal rat liver, TRb 1 protein was observed faintly in the parenchyma of the liver (Fig. 6I) . After birth, expression had become much stronger in the hepatocytes surrounding the central veins ( Fig. 6L ; cf. (Zandieh Doulabi et al. 2002) ). The protein: mRNA ratios for TRa 1 , TRa 2 , and TRb 1 did not change appreciably with development.
Kidney
The development of the definitive kidney is characterized by the penetration of the ureteric bud into the metanephric mass. The metanephric tubules expressed TRb mRNA (Fig. 7B, D and F) , whereas the ureteric buds and surrounding mesenchyme expressed TRa mRNA (Fig. 7A, C and E) . TRa 2 mRNA levels were more than ten times higher than TRa 1 levels (Fig. 2D) . Both TRa 1 and TRa 2 mRNA concentrations peaked perinatally, whereas TRb 1 mRNA peaked just after birth. TRb 2 mRNA was undetectable.
TRa 1 protein levels increased perinatally, with a band of 30 kDa, which is also present in liver extracts, becoming more prominent with age ( Fig. 3A and B) . At E18, TRa 1 protein was weakly present in the nephric tubules (Fig. 7G ), but had disappeared at P4 (Fig. 7J ).
TRa 2 protein was not detectable in any cell type in the kidney (Fig. 7H and K) . TRb 1 protein was detected in the glomeruli and tubules at E18 (Fig. 7I) . After birth, the glomeruli were no longer positive (Fig. 7L ). The protein:mRNA ratio for TRa 1 and TRa 2 did not change appreciably in development. If, however, the 30 kDa band is a proper TRa 1 gene product, the protein: mRNA ratio for TRa 1 does increase with development. The protein:mRNA ratio for TRb 1 declined with development, but in the adult, a 30 kDa band that was also seen in liver, had become very prominent. If this is a bona fide TRb 1 gene product, the ratio is substantially higher in the adult.
Adrenals
TRa mRNA, which was still found in the entire adrenal at E16 (Fig. 7A) , had become confined to dispersed islands of cells in the medulla and the capsule at E18 (Fig. 7C) . TRb mRNA levels were low and confined to the capsule ( Fig. 7B and D) . PCR analysis was not performed. Western blot analysis showed prominent bands for both TRa 1 and TRa 2 after birth ( Fig. 3B and E). The TRa 2 antibody produced an additional 100 kDa band. This band was also observed in human (not shown), but not in rat pituitary gland. Only one band was observed for TRb 1 protein (Fig. 3F) . The TRa 1 protein was diffusely distributed in the adrenal at E18 (Fig. 8A ), but had become confined to the adrenal medulla at P4 (Fig. 8D) . The distribution of TRa 2 protein was confined to well-defined islets of cells at E18 (Fig. 8B) and to the medulla after birth (Fig. 8E) . The TRb 1 protein was diffusely distributed in the adrenal tissue and capsule at E18 (Fig. 8C ), but became localized to the adrenal cortex after birth (Fig. 8F) . The morphological data indicate that the TRa mRNA in the adrenal capsule does not generate detectable protein. In contrast, the low abundance of TRb mRNA and the readily detectable TRb 1 protein in sections indicate a high protein:mRNA ratio.
Intestines
The epithelial layer of the intestines (Fig. 9A-F) and the parenchymal cells of the pancreas (Fig. 9C and D) co-expressed TRa and TRb mRNA from E16 onward (Fig. 9A-F) . Between E18 and E20, both TRa and TRb mRNAs became confined to the crypts. TRa 1 , TRa 2 , and TRb 1 mRNA levels followed a similar developmental pattern and peaked perinatally ( Fig. 2E and F) .
Western blotting showed that TRa 1 protein levels decreased between 5 days before birth and 4 days after birth ( Fig. 3A and C) . The opposite was true for TRa 2 protein ( Fig. 3D and F) . Relatively low levels of TRb 1 protein were found both pre-and postnatally ( Fig. 3G  and I ). The TRa 1 antiserum generated staining at the apical surface of the enterocytes at E18, but not at P4 ( Fig. 9G and J) . TRa 2 protein could not be detected ( Fig. 9H and K) . In contrast, strong staining for TRb 1 protein was observed in the smooth-muscle layer of the intestine at E18 (Fig. 9I ) and P4 (Fig. 9L) , as opposed to a relatively weak staining in the mucosa. The TRa mRNAs, therefore, generated very little protein in the epithelium. The protein:mRNA ratio for TRb 1 in the epithelium was also low. At the same time, high levels of TRb 1 protein were present in the smooth muscle layer, where the corresponding mRNA was barely detectable.
Comparison of TR protein in organs
We demonstrated the presence of TRa 1 and TRa 2 proteins on western blots of several other organs (Fig. 3 , Table 1 ). Quantification showed that the concentrations of TRa 1 protein in lung, muscle, heart, kidney, adrenals, pituitary gland, spinal cord, testis, and fat pad were similar, that in brain, liver, and small intestine were approximately threefold lower, and that in trachea and red blood cells were twofold higher than average. Average concentrations of TRa 2 were found in liver, small intestine, and kidney, a very low concentration in red blood cells, approximately twofold lower than average concentrations in lung, trachea, muscle, heart, spinal cord, and brain, and twofold higher than average in the fat pad, testis, and adrenals. The resulting TRa 1 :TRa 2 ratio, a parameter for tissue thyroid hormone responsiveness, was 3-to 10-fold lower than average in brain, liver, prenatal heart, lung, postnatal small intestine, adrenals, and fat pad; 2-to 10-fold higher than average in postnatal lung, trachea, muscle, and pituitary gland, and extremely high for blood. The TRa 1 :TRa 2 ratio declined with the development in liver and small intestine, and increased in lung, muscle, heart, and brain. The TRb 1 concentration was remarkably similar in all analyzed organs before birth and, after birth, relatively low in muscle, bone, fat pad, small intestine, and red blood cells, and relatively high in brain and spinal cord.
Comparison of the protein:mRNA ratio between organs
Protein synthesis is determined by the corresponding steady-state mRNA level and translational efficiency, whereas the steady-state protein level is determined by its synthesis (translation) and degradation. If we assume that no major changes occurred in the tissue concentration of polyA C mRNA or total protein with time and that TR mRNAs are not sequestered from Thyroid hormone receptor expression in perinatal lung. TRa mRNA was prominently present in the lung mesenchyme at E15 (A) and E18 (C). TRb mRNA in the pulmonary epithelium is visible at E15 (B) and pronounced at E18 (D). Note the complementarity of TRa and TRb mRNA expression (C and D). Thereafter (E and F: E20), the complementary distribution was no longer demonstrable. The pulmonary vein is identifiable by its expression of TRa (C), whereas the pulmonary artery is characterized by TRb expression in its myocardial wall (D and F; arrowheads). TRa 1 (G and J) and TRa 2 proteins (H and K) were undetectable at E18 (G and H) and P4 (J and K). TRb 1 protein was largely confined to the epithelium and detectable at both E18 (I) and P4 (L). Arrows, terminal bronchioli ('canaliculi'); asterisk, terminal bronchioli and alveoli. Bar, 100 mm.
the translational machinery at a specific time point, protein:mRNA ratios inform us about the presence of a posttranscriptional level of regulation of gene expression (cf. Table 1) . During lung development, the protein:mRNA ratio of TRa 1 increased, but the ratios of TRa 2 and TRb 1 remained more or less constant. Similarly, the protein:mRNA ratios for TRa 1 , TRa 2 , and TRb 1 did not change appreciably with liver and kidney development. During intestinal development, the TRa and TRb mRNAs generated very little protein in the epithelium, but the reverse was true for the smooth muscle layer, where a barely detectable TRb 1 mRNA generated a high concentration of protein.
In the brain, the protein:mRNA ratio was very low for TRa 1 and TRa 2 , whereas that for TRb 1 was highest.
Discussion
Despite the detailed insights into the molecular mechanisms underlying the thyroid hormone-and TR-dependent modulation of gene expression that are now available (Cheng 2000 , Zhang & Lazar 2000 , Baxter et al. 2001 , Yen 2001 , O'Shea & Williams 2002 , Chassande 2003 , Flamant & Samarut 2003 and the undisputed role of thyroid hormone in organogenesis (Oppenheimer & Schwartz 1997 , Tata 1999 , the mechanistic aspects of thyroid hormone action in development are still debated. Nevertheless, it is likely that epithelial-mesenchymal interactions play a role, because mesenchymal cells are thought to be primary determinants of epithelial cell fate during organogenesis (Brard 1990) . Using in situ hybridization and immunohistochemistry as visualization techniques, and RT-PCR and western blotting as quantification techniques, we indeed observed a highly specific distribution pattern of the TR isoforms that appears to support such a mechanism of action for thyroid hormones. Expression of the TRa isoform was observed in the mesenchymal tissues and expression of the TRb isoform in the epithelial tissues of lung, liver, kidney, sensory system of the inner ear, and bone. As far as we know, this generalization has not been made so far. However, this generalization did not apply to the central nervous system and the intestine. In addition, the relation was obscured by an extensive posttranscriptional regulation of the expression of the TRs, with differences between organs and between different developmental stages of the same organ Thyroid hormone receptor expression in perinatal liver. TRa mRNA was readily detectable in prenatal liver mesenchyme (A, E15; C, E17; E, E20). Expression declined in liver stroma, but became more prominent in the developing perivascular mesenchyme. TRb mRNA was also readily detectable at E15 (B), temporarily declined (D; E17), but had reappeared in the hepatocytes at E20 (F). Note the complementarities of TRa and TRb mRNA expressions (E and F). At E18 (G), TRa 1 protein concentration was barely detectable, but at P4 (J), it had accumulated in the pericentral hepatocytes. Similarly, TRa 2 protein was undetectable before birth (H, E18), but was observed in isolated liver cells after birth (K, P4). TRb 1 protein was present in most hepatocytes before birth (I), but had become confined to the pericentral hepatocytes by P4 (L). Li, liver; Lu, lung; G, gonad; P, portal vein; C, central vein. Bar, 100 mm.
(cf. also (Strait et al. 1990 , Lane et al. 1991 , Rodd et al. 1992 , Schwartz et al. 1992 , Weiss et al. 1998 ). In this respect, it is of interest that the protein:mRNA ratios that we derived for brain, liver, and kidney resemble those derived by Oppenheimer and Schwartz (Oppenheimer & Schwartz 1997 ) with respect to the TRa 1 , but, in contrast to their findings, we concluded that the TRb 1 protein:mRNA ratio is higher in brain than in liver.
The complementary expression pattern of TRa and TRb was most pronounced in developing lung, liver, and kidney, that is, in organs with distinct epithelial and mesenchymal components. Since most epithelia cannot differentiate when separated from their associated mesenchyme (Birchmeier & Birchmeier 1993) , it is thought that epithelial differentiation is under control of its underlying mesenchyme. The respective expression patterns were much more pronounced at the mRNA than at the protein level, implying important posttranscriptional control mechanisms. Although both mRNA and protein levels in the organs mentioned reached maximal levels perinatally, it is of interest that for those organs, for which paired samples were available, tissue TRa 2 and TRb 1 protein peaked at 5 days before birth. In contrast, TRa 1 protein follows a similar time course as circulating thyroid hormones (Dubois & Dussault 1977) to reach its highest level after birth. This latter temporal association is in line with the finding that unliganded TRa1 is detrimental to postnatal development (Chassande 2003) . Our data, therefore, suggest that an initiating, (unliganded) TRbmediated role of the epithelium induces a TRamediated response of the mesenchyme.
On the other hand, extensive co-expression of TRa and TRb was observed in the developing brain and intestinal epithelium. Despite the high level of TRa 1 and particularly TRa 2 mRNA in these organs, TRa 1 protein levels were much lower, and TRa 2 protein levels were similar to those in the other organs investigated. In other words, organs with co-expression of TRa and TRb in the same cells seem to be characterized by a very low TR protein:mRNA ratio in the perinatal period. Thus, the protein:mRNA ratio for TRa 1 was more than tenfold lower and that of TRa 2 15-to 50-fold lower in perinatal brain than in perinatal liver, lung, or kidney. In contrast, the protein:mRNA ratio for TRb 1 was similar in these four organs in this period, but was very low in intestinal epithelium, especially before birth. This implies that in organs with co-expression of TRa and TRb, the translational efficiency of one of the TR mRNAs is much lower, and/or that the turnover of TR protein is much higher than that in cells without Thyroid hormone receptor expression in perinatal kidney. TRb mRNA was present in the developing nephrons from E16 onwards (B, E16; D, E18; F, E20). TRa mRNA was present in the surrounding mesenchyme, but declined with development (A, E16; C, E18; E, E20). TRa 1 protein was seen in the collecting tubules at E18 (G), but had disappeared at P4 (J). TRa 2 protein was not detectable at either E18 (H) or P4 (K). At E18, TRb 1 protein was present in the glomeruli and, more abundantly, in the collecting tubules (I). After birth, TRb 1 protein had disappeared from the glomeruli (L). At E16, TRa mRNA was weakly expressed in the entire adrenal (A), but had become largely confined to the capsule at E18 (C). A weak staining for TRb mRNA was seen in the capsule of the adrenals (B and D). Ad, adrenal; K, kidney with U, ureter; C, cortex; G, glomerulus; and CT, collecting tubules. Bar, 100 mm.
co-expression. These data indicate that the TR-dependent regulatory cascades function differently in those organs in which the TRa and TRb genes are characterized by a complementary expression pattern and those in which they are co-expressed. Intriguingly, these posttranscriptional regulatory mechanisms, therefore, largely annul the apparent dominance of TRa 2 expression in the central nervous system and that of TRb 1 expression in the intestine. We observed an apparent discrepancy between the relatively weak staining of TRa proteins in histological sections of all organs except the adrenal, and their strong presence, in particularly TRa 1 , on western blots. Although one explanation would be that the TRas were not well accessible in the tissue sections of most organs, the use of a denaturing rather than a cross-linking fixative and absence of an effect of preprocessing the sections with antigen-retrieval techniques shows that, more likely, they are distributed over many more cells, hence that the cellular concentration remains too low to strongly stain these tissues. This interpretation suggests a more homogeneous distribution of TRas than TRb 1 in brain, lung, bone, and kidney. In agreement, the TRa 1 and TRa 2 proteins stained homogeneously in the anterior pituitary gland (Fig. 4) , while the TRa 1 protein had a much wider pericentral expression pattern in the liver than the Thyroid hormone receptor expression in perinatal intestine. Note that TRa and TRb mRNAs are co-expressed in the epithelium of the intestines at E16 (A and B), E18 (C and D), and E20 (E and F). From E18 onwards, both mRNAs became concentrated in the crypts. Also note the expressions of TRa and TRb mRNA in the pancreatic epithelium (C and D). TRa 1 protein staining was present in the apical part of the villar epithelium before (G), but not after birth (J). TRa 2 protein was not detectable (H and K). TRb 1 protein was seen predominantly in the smooth muscle layer and to a lesser extent in the epithelium of the intestine at E18 (I), and equally at both the locations after birth (L). C, crypt; V, villus; P, pancreas; SM, smooth-muscle layer. Bar, 100 mm. Thyroid hormone receptor expression in the adrenal glands. TRa 1 protein was present in most parenchymal cells of the adrenal at E18 (A), but had become confined to the adrenal medulla at P4 (D). TRa 2 protein was confined to islets of cells at E18 (B) and to the adrenal medulla after birth (E). TRb 1 protein was seen to be present in the adrenal and its capsule at E18 (C), but became concentrated in the adrenal cortex after birth (F). C, cortex and M, medulla of adrenal gland. Bar, 100 mm.
TRb 1 protein ( Fig. 6 ; cf. also Zandieh Doulabi et al. 2002 Doulabi et al. , 2003 .
We detected 8 . 9G2 . 4 amol TRb 2 mRNA in adult rat pituitary gland, but were unable to detect this TRb isoform outside the pituitary, implying that TRb 2 mRNA concentrations were more than 1000-fold lower. Nevertheless, we detected abundant staining in many organs with four rabbit antisera that were raised against a TRb 2 -specific oligopeptide (data not shown). In the pituitary, staining was most pronounced in the intermediate lobe of the pituitary, as was reported earlier (Li & Boyages 1997) . The putative TRb 2 protein was 47 kDa, i.e., 11 kDa less than predicted by the reported open reading frame (Hodin et al. 1989) . Although the size of this protein corresponds with the TRb 3 isoform (Williams 2000) , the oligopeptide used for immunization is not present in TRb 3 . Possibly, TRb 2 uses a more downstream translation initiation site (cf. (Wood et al. 1994) ). The pI of the putative TRb 2 protein was 7 . 6 in liver (corresponding with that of the unmodified TRb 2 protein) and 5 . 0 in the pituitary gland.
Extremely low cellular levels of TRb 2 mRNA in association with easily detectable TRb 2 protein levels outside the pituitary gland were reported before (Lechan et al. 1993 , Schwartz et al. 1994 , Ercan-Fang et al. 1996 , Oppenheimer & Schwartz 1997 . Presently, gene targeting is one of the most powerful approaches to establish causal relations between gene expression and phenotype. The analysis of single and compound mutations of the Thra and Thrb loci has revealed that TRa 1 and TRb 1 cooperate and can partially substitute for each other, and that the consequences of thyroid hormone deficiency differ from those of TR deficiency (O'Shea & Williams 2002) . TRb 1 expression appears to be preferentially associated with the development of the cochlea and liver gene expression (Forrest et al. 1996 , Weiss et al. 1998 ; cf. Figs 1 and 6), whereas TRb 2 appears to be responsible for the development and maintenance of the hypothalamic-pituitary axis (Abel et al. 1999) . As suggested by the pronounced phenotype of hypothyroid neonates, unoccupied TRbs can interfere with normal development as well (Hashimoto et al. 2001) . TRa 1 expression appears to be more closely associated with intestinal, cardiac, and bone development (Wikstrom et al. 1998 , Plateroti et al. 1999 ). In agreement with our immunohistochemical data (cf. Figs 4 and 6 with Fig. 9 ), the effects of TRa deficiency become evident at weaning, that is, substantially later than those of TRb deficiency. However, the expression and function of TRa 1 is materially complicated by the other products of the Thra locus, TRa2, and the TRDa isoforms (O'Shea & Williams 2002 , Flamant & Samarut 2003 . Thus, TRa 1 deficiency differs from TRa 1/2 deficiency in the more severe phenotype of the latter, with hypothyroidism, runting, and maturational delays in bone and intestinal development that become manifest at weaning (Fraichard et al. 1997) . In contrast, TRa 0/0 mice that lack all products from the Thra locus, including TRDa, have a milder phenotype than TRa 1/2 -deficient mice (Macchia et al. 2001) , due to the absence of the effects of TRDa (Plateroti et al. 2001) . Irrespective of these complexities, our study has shown that the developmental appearance of the respective TR proteins corresponds nicely with the phenotypes of mutations of the corresponding genes.
